The MedTech and Life Sciences Geopolitical Landscape

MedTech and Life Sciences profitability is being reshaped by more than competition, it is increasingly driven by global geopolitical forces. From tariffs and centralized procurement in China to U.S. drug pricing reforms, policy shifts are now central to strategy and earnings. This report examines both long-standing and emerging pressures and outlines how enterprises can adapt to protect margins and sustain growth.

Inside you’ll find:

• How tariffs are creating 8 figure cost impacts for major device manufacturers.
• Why pricing reforms in China and the U.S. are compressing margins.
• What forward-looking organizations are doing to protect profitability.